help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1455
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/6/3342    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chevalley, T.
Right arrow Articles by Rizzoli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chevalley, T.
Right arrow Articles by Rizzoli, R.
Related Collections
Right arrow Adrenal and Hypertension
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 6 3342-3349
Copyright © 2005 by The Endocrine Society

Skeletal Site Selectivity in the Effects of Calcium Supplementation on Areal Bone Mineral Density Gain: A Randomized, Double-Blind, Placebo-Controlled Trial in Prepubertal Boys

T. Chevalley, J.-P. Bonjour, S. Ferrari, D. Hans and R. Rizzoli

Service of Bone Diseases (World Health Organization Collaborating Centre for Osteoporosis Prevention), Department of Rehabilitation and Geriatrics (T.C., J.-P.B., S.F., R.R.) and Service of Nuclear Medicine, Department of Radiology (D.H.), University Hospitals of Geneva, CH-1211 Geneva 14, Switzerland

Address all correspondence and requests for reprints to: Thierry Chevalley, M.D., Service of Bone Diseases, Department of Rehabilitation and Geriatrics, University Hospitals of Geneva, CH-1211 Geneva 14, Switzerland. E-mail: thierry.chevalley{at}hcuge.ch.

Background: Calcium supplementation during childhood and adolescence is considered an early means of preventing osteoporosis in adults. Prepuberty is an opportune time for detecting the benefits of calcium in girls.

Objective: The objective was to assess whether calcium supplementation increases bone mass gain in prepubertal boys in a skeletal site-specific manner.

Methods: In a 12-month double-blind, placebo-controlled trial with 1-yr follow-up, 235 healthy prepubertal boys aged 7.4 ± 0.4 yr (mean ± SD) were randomized to receive two food products providing 850 mg/d calcium (calcium supplement group, n = 116) or an isocaloric placebo (n = 119). Areal bone mineral density (aBMD) was determined by dual-energy x-ray absorptiometry at radius (two sites), hip (two sites), femoral diaphysis (FDia), and L2–L4 vertebrae.

Results: At 12 months, aBMD gain was greater at the FDia and at the mean of the five appendicular skeletal sites in the calcium supplement group in both intention-to-treat analysis [76 ± 32 vs. 64 ± 33 mg/cm2·yr; difference, 12.0 (95% confidence interval, CI, 3.6–20.3), P = 0.006; and 33 ± 16 vs. 28 ± 16 mg/cm2·yr; difference, 5.1 (95% CI, 0.9–9.2); P = 0.018, respectively] and active treatment analysis [81 ± 32 vs. 64 ± 31 mg/cm2·yr; difference, 17.2 (95% CI, 7.9–26.5); n = 174, P < 0.001; and 35 ± 16 vs. 28 ± 14 mg/cm2·yr; difference, 7.5 (95% CI, 2.9–12.2); P = 0.002]. There was no beneficial effect of calcium on lumbar spine. The calcium effect was still detectable by ANOVA repeated measures analysis at the FDia (P = 0.004) and at the mean of the five appendicular skeletal sites (P = 0.002) 1 yr after the end of intervention (active treatment analysis). There was no change in bone size.

Conclusion: In prepubertal boys, calcium-enriched foods increased aBMD at several appendicular skeleton sites, but not at the lumbar spine, and this without any bone size change. This effect was maintained 1 yr after treatment discontinuation.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. Richert, T. Chevalley, D. Manen, J.-P. Bonjour, R. Rizzoli, and S. Ferrari
Bone Mass in Prepubertal Boys Is Associated with a Gln223Arg Amino Acid Substitution in the Leptin Receptor
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4380 - 4386.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Gugatschka, H. Dobnig, A. Fahrleitner-Pammer, P. Pietschmann, S. Kudlacek, A. Strele, and B. Obermayer-Pietsch
Molecularly-defined lactose malabsorption, milk consumption and anthropometric differences in adult males
QJM, December 1, 2005; 98(12): 857 - 863.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society